WEBINAR: AT-Closed Vial® and Container Closure Integrity during Cryogenic Storage

Jean-Sébastien Parisse, Commercial Director of Aseptic Technologies, animates the webinar on the Container Closure Integrity (CCI) at cryogenic temperatures, explaining how the AT-Closed Vial® ensures safe cryopreservation and delivery to patients of the cell and gene therapy products.

About AT-Closed Vial Technology: http://www.aseptictech.com/products/c...
The white paper referred in the webinar: http://www.aseptictech.com/sites/defa...

Get in touch with us via LinkedIn:   / aseptictechnologies  

About Aseptic Technologies:
Aseptic Technologies, part of SKAN Group, is a globally acting developer and manufacturer of the fill and finish solutions for novel biotechnology products. AT is particularly known for the AT-Closed Vial Technology, based on vial and process of the unique design.
Within last 10 years, AT has accompanied over three hundred players of the cell and gene therapy field, contributing to their bringing in-house, scaling-out and scaling-up manufacturing strategy, gaining a tremendous experience in de-risking of the process and providing the absolute resistance of the filled vials to cryopreservation.